股本结构
单位：万股
| 公告日期 | 2026-03-19 | 2025-11-24 | 2025-11-17 | 2025-11-13 | 2025-06-27 | 2025-05-27 |
|---|---|---|---|---|---|---|
| 证券总股本 | 4366.24 | 4302.65 | 3876.07 | 3754.48 | 3743.56 | 3742.93 |
| 普通股本 | 4366.24 | 4302.65 | 3876.07 | 3754.48 | 3743.56 | 3742.93 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-02-20 | 2025-11-20 | 2025-11-18 | 2025-09-30 | 2025-06-27 | 2025-05-23 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-03-19 | 4366.24 | 未披露 | 定期报告 | 2026-02-20 |
| 2025-11-24 | 4302.65 | 未披露 | 定期报告 | 2025-11-20 |
| 2025-11-17 | 3876.07 | 未披露 |
更多>>
Ordinary Share offered 1,215,964 shares by the company
|
2025-11-18 |
| 2025-11-13 | 3754.48 | 未披露 | 定期报告 | 2025-09-30 |
| 2025-06-27 | 3743.56 | 未披露 | 定期报告 | 2025-06-27 |
| 2025-05-27 | 3742.93 | 未披露 | 定期报告 | 2025-05-23 |
| 2024-12-02 | 3742.73 | 未披露 | 定期报告 | 2024-11-27 |
| 2024-10-07 | 3738.90 | 未披露 |
更多>>
Ordinary shares offered 3,000,000 shares by the company
|
2024-10-07 |
| 2024-10-10 | 3438.90 | 未披露 | 定期报告 | 2024-09-27 |
| 2024-07-01 | 3437.30 | 未披露 | 定期报告 | 2024-06-28 |
| 2024-05-31 | 3436.04 | 未披露 |
更多>>
Nyxoah announced today that the underwriters of the Offering have exercised their option to purchase additional shares for 300,000 shares at the public offering price of $9.25 (EUR 8.54) per share, before underwriting discounts and commissions.
|
2024-06-03 |
| 2024-05-24 | 3406.04 | 未披露 |
更多>>
Ordinary shares offered 5,374,755 shares by the company
|
2024-05-28 |
| 2024-05-14 | 2868.56 | 未披露 |
更多>>
On April 17, 2024, the Company issued 3,000 shares pursuant to an exercise of 3,000 ESOP 2021 Warrants.
|
2024-04-17 |
| 2024-03-20 | 2868.26 | 未披露 | 定期报告 | 2024-03-18 |
| 2023-11-08 | 2867.40 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-07-28 | 2866.40 | 未披露 | 定期报告 | 2023-07-27 |
| 2023-05-16 | 2828.70 | 未披露 | 定期报告 | 2023-03-31 |
| 2022-10-03 | 2584.63 | 未披露 | 定期报告 | 2022-09-30 |
| 2022-07-01 | 2583.63 | 未披露 | 定期报告 | 2022-06-30 |
| 2022-02-14 | 2579.74 | 未披露 | 定期报告 | 2022-02-11 |
| 2021-11-29 | 2577.24 | 未披露 | 定期报告 | 2021-11-26 |
| 2021-11-01 | 2565.74 | 未披露 | 定期报告 | 2021-10-29 |
| 2021-07-09 | 2536.79 | 未披露 |
更多>>
1.Nyxoah announced today that the underwriters of the Offering have exercised their option to purchase additional shares in full. The option to purchase additional shares granted to the underwriters was for the purchase of up to an additional 425,250 new ordinary shares, at the public offering price of US$30 per share, before underwriting discounts and commissions.
|
2021-07-09 |
| 2021-07-06 | 2494.26 | 未披露 |
更多>>
1.Ordinary shares offered by the company 2,835,000 ordinary shares
2.The number of ordinary shares that will be outstanding after this offering is based on 22,107,609 ordinary shares outstanding as of March 31, 2021
|
2021-07-02 |
Ordinary Share offered 1,215,964 shares by the company
Ordinary shares offered 3,000,000 shares by the company
Nyxoah announced today that the underwriters of the Offering have exercised their option to purchase additional shares for 300,000 shares at the public offering price of $9.25 (EUR 8.54) per share, before underwriting discounts and commissions.
Ordinary shares offered 5,374,755 shares by the company
On April 17, 2024, the Company issued 3,000 shares pursuant to an exercise of 3,000 ESOP 2021 Warrants.
1.Nyxoah announced today that the underwriters of the Offering have exercised their option to purchase additional shares in full. The option to purchase additional shares granted to the underwriters was for the purchase of up to an additional 425,250 new ordinary shares, at the public offering price of US$30 per share, before underwriting discounts and commissions.
1.Ordinary shares offered by the company 2,835,000 ordinary shares
2.The number of ordinary shares that will be outstanding after this offering is based on 22,107,609 ordinary shares outstanding as of March 31, 2021